Biocon Limiteds credit ratings were reaffirmed at CRISIL AA+/Stable for long-term and A1+ for short-term on its bank facilities of Rs. 250 Crore. The companys revenue was Rs. 7,023 crore, showing a 2% growth year-on-year, with operational improvements anticipated in the second half of fiscal 2025.